老年心脏瓣膜置换术中应用瑞马唑仑对患者脏器功能的保护作用研究
CSTR:
作者:
作者单位:

(运城市中心医院麻醉科,山西 运城 044000)

作者简介:

通讯作者:

中图分类号:

基金项目:

山西省医师协会临床科研项目(YSXH-RF2022MZ008)


Predictive effect of remimazolam on organ function in elderly patients undergoing cardiac valve replacement
Author:
Affiliation:

(Department of Anesthesiology, Yuncheng Central Hospital, Yuncheng 044000, Shanxi Province, China)

Fund Project:

This work was supported byClinical Research Project of Shanxi Medical Doctor Association(YSXH-RF2O22MZOO8).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨瑞马唑仑在老年心脏瓣膜置换术中的应用效果及其对脏器功能的保护作用。方法 前瞻性选取2023年1月至2025年1月山西省运城市中心医院收治的130例行择期心脏瓣膜置换术的老年患者为研究对象。根据随机数字表法将患者分为研究组(采用瑞马唑仑行麻醉诱导及维持)及对照组(采用丙泊酚行麻醉诱导及维持),各65例。记录两组患者麻醉诱导前(T0)、插管时(T1)、切皮时(T2)及锯胸骨时(T3)的血流动力学参数[平均动脉压(MAP)、心率(HR)];分别于术前及术后3 d采集患者外周静脉血,检测肝、肾功能及心肌损伤标志物水平;记录患者术中及术后麻醉相关不良反应以及术中镇静效果。采用SPSS 27.0统计软件进行数据分析。根据数据类型,组间比较分别采用独立样本t检验、χ2检验、Fisher确切概率法或连续矫正卡方检验,组内比较采用配对t检验。结果 研究组T0~T3时间点的MAP依次为(94.15±6.48)、(88.15±7.73)、(79.36±7.46)、(80.33±8.04)mmHg(1 mmHg=0.133 kPa),对照组依次为(95.03±8.11)、(77.54±7.91)、(74.39±7.49)、(76.98±7.15)mmHg。研究组T0~T3时间点的HR依次为(80.39±7.25)、(81.39±6.98)、(69.43±7.29)、(75.82±7.33)times/min,对照组依次为(81.05±8.83)、(74.17±7.49)、(64.35±6.87)、(68.04±7.04)times/min。研究组及对照组围术期不同时间点MAP及HR波动差异均有统计学意义(均P<0.05),且研究组T1、T2、T3时间点MAP及HR水平均高于对照组,差异均有统计学意义(均P<0.05)。与术前相比,两组术后3 d尿氮素、谷草转氨酶(AST)、N末端B型利钠肽前体、肌钙蛋白I(CTnI)及肌酸激酶同工酶水平均上升(P<0.05);对照组术后3 d血肌酐(SCr)较术前上升,估算肾小球滤过率(eGFR)水平较术前下降(P<0.05);研究组手术前后SCr、eGFR无明显改变(P>0.05)。且研究组术后3 d SCr、AST及CTnI水平低于对照组,差异均有统计学意义(P<0.05)。研究组术中低血压以及注射痛发生率低于对照组,差异均有统计学意义(均P<0.05)。两组术中诱导期和维持期补救患者占比以及镇静成功率比较,差异均无统计学意义(均P>0.05)。结论 瑞马唑仑应用于老年瓣膜置换术中的镇静效果良好,在减小患者围术期血流动力学波动,保护各脏器功能以及减少术中不良反应中均具有良好价值。

    Abstract:

    Objective To investigate the effect of remimazolam in elderly patients undergoing cardiac replacement and its protective effect on organ function. Methods Prospectively, a total of 130 elderly patients undergoing elective cardiac valve replacement admitted to Yuncheng Central Hospital from January 2023 to January 2025 were enrolled as study subjects. The patients were divided into a study group (using remimazolam for anesthesia induction and maintenance) and control group (using propofol for anesthesia induction and maintenance) by a random number table method, with 65 cases in each group. Hemodynamic parameters [mean arterial pressure (MAP) and heart rate (HR)] were recorded in the two groups before anesthesia induction (T0), during intubation (T1), during skin incision (T2), and during sternal sawing (T3). Peripheral venous blood was collected before surgery and at day 3 after surgery to assess liver and kidney function and myocardial injury markers. The intraoperative and postoperative anesthesia-related adverse reactions and intraoperative sedation effectiveness were recorded. SPSS 27.0 was used for data processing. According to the data type, independent sample t test, χ2, Fisher′s exact test, or continuity-corrected Chi-square test, was performed for intergroup comparisons, and paired t test was used for intragroup comparisons. Results MAP values in the study group at T0-T3 were (94.15±6.48), (88.15±7.73), (79.36±7.46), and (80.33±8.04) mmHg (1 mmHg=0.133 kPa), respectively; in the control group, they were (95.03±8.11), (77.54±7.91), (74.39±7.49), and (76.98±7.15) mmHg, respectively. HR values in the study group at T0-T3 were (80.39±7.25), (81.39±6.98), (69.43±7.29), and (75.82±7.33) beats/min, respectively; in the control group, they were (81.05±8.83), (74.17±7.49), (64.35±6.87), and (68.04±7.04) beats/min, respectively. MAP and HR fluctuations at different perioperative time points were statistically significant in both groups (P<0.05), MAP and HR levels in the study group were significantly higher than those in the control group at T1, T2, and T3 (P<0.05). Compared with preoperative levels, levels of blood urea nitrogen, aspartate aminotransferase (AST), N-terminal pro-B-type natriuretic peptide, cardiac troponin I (CTnI), and creatine kinase isoenzyme-MB increased in both groups at day 3 after surgery (P<0.05). In control group, serum creatinine (SCr) at day 3 after surgery was significantly higher and estimated glomerular filtration rate (eGFR) was significantly lower than those before surgery (P<0.05) . No significant changes in SCr and eGFR were observed in the study group before and after surgery (P>0.05). SCr, AST, and CTnI levels in the study group were significantly lower than those in the control group at day 3 after surgery, with statistically significant differences (P<0.05). The incidence rates of intraoperative hypotension and injection pain were lower in study group than those in control group (P<0.05). There were no statistical differences in the proportions of remedial cases during induction and maintenance or in sedation success rate between the two groups in intraoperative(P>0.05). Conclusion Remimazolam has a good sedation effect in elderly patients undergoing valve replacement and is valuable in reducing perioperative hemodynamic fluctuations, protecting organ functions and reducing intraoperative adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

李雁军,王伟,王银鸽.老年心脏瓣膜置换术中应用瑞马唑仑对患者脏器功能的保护作用研究[J].中华老年多器官疾病杂志,2026,25(6):458-463
DOI:10.11915/j. issn.1671-5403.2026.06.093

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-06-14
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-07-03
  • 出版日期:
文章二维码